31 Mar Wacker
Wacker Biotech is “YOUR MICROBIAL CDMO FOR ADVANCED THERAPEUTICS” – partner of choice for process development and commercial manufacturing of biopharmaceuticals (therapeutic proteins, vaccines, live microbial products, and plasmid DNA (pDNA)) using microbial hosts. Developed over decades, PLASMITEC®, our plug-and-play platform for pDNA is suitable for manufacturing R&D supplies (non-GMP) up to scale-up to full GMP-compliant production. Wacker Biotech’s integrated service portfolio covers molecular biology, process- and analytical development as well as GMP manufacturing of biologics for clinical and commercial supply. Wacker Biotech maintains four GMP-compliant, FDA- and EMA-certified production plants in Amsterdam (The Netherlands), San Diego (US) and in the German cities of Jena and Halle. Wacker Biotech GmbH, Wacker Biotech B.V. and Wacker Biotech US Inc. are wholly-owned subsidiaries of the Munich-based WACKER Group.
